Startups

Argobio Studio logo

Argobio Studio

argobiostudio.com

Argobio Studio is a Paris-based operational biotechnology venture builder established in 2021. It sources early therapeutic projects from European academic research, co-founds and invests in companies, and embeds drug discovery, development and business expertise to advance them toward seed and Series A financing. Its programs span neuroscience, rare diseases, oncology and immunology. Its portfolio includes Elkedonia's ELK1-targeted depression program, alongside RNA, gene-therapy and protein-degradation platforms.

Team

Aurore BesseScientific Project Manager
Aurore HickScientific Project Manager
Céline SoulanFinance Manager
Daniel SobralPartner and Chief Financial Officer
Morgane SchwenzerOffice Manager
Neill Moray MackenziePartner and Entrepreneur in Residence
Nicolas BillialdAssociate and Business Manager
Oscar CastanonSenior Associate and Business Developer
Poul SørensenPartner and Entrepreneur in Residence
Rémi SoulaPartner and Entrepreneur in Residence
Thierry LaugelChairman
Yves RibeillPartner and Entrepreneur in Residence

Investments